Drug details

Somavert (pegvisomant)

type of Metabolic & Endocrine, Other

Somavert (pegvisomant) is a manufactured protein similar to human growth hormone (HGH) used for the treatment of acromegaly (a growth disorder caused by too much growth hormone).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• upper stomach pain,
• loss of appetite,
• itching,
• dark urine,
• clay-colored stools, and
• yellowing of the skin or eyes (jaundice)
• easy bruising,
• wheezing,
• tired feeling,
• thickening of the skin or a hard lump where you injected the medicine,

The following drugs are related to Somavert, either as a replacement or used together:

• Xultophy Injection (insulin degludec and liraglutide)
• Somatuline Depot (lanreotide)
• Mycapssa (octreotide oral capsules)
• Sandostatin (octreotide acetate)
• Sandostatin LAR (octreotide acetate injection)
• Signifor-LAR (pasireotide for injectable suspension, for intramuscular use)
• Regonol (pyridos tigmine bromide injection)